Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.77 |
| ▸ | PTPN1 | P18031 | 6/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | TTR | P02766 | 1/20 | 0.58 |
| ▸ | TYR | P14679 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Shinpterocarpin SCHEMBL29377666 | 1.00 | MGAM (0.77) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL29929606 | 0.87 | MGAM (1.00) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL33736 | 0.87 | MGAM (1.00) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL33735 | 0.87 | MGAM (1.00) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL29351585 | 0.87 | MGAM (1.00) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL28856370 | 0.86 | MGAM (0.98) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| SCHEMBL13794192 | 0.85 | MGAM (0.59) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Leiocarpin SCHEMBL29352437 | 0.85 | MGAM (0.59) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL28201435 | 0.83 | MGAM (0.90) | MGAMPTPN1CYP3A4NPC1HSP90AA1 | |
| Phaseolin SCHEMBL28209786 | 0.82 | MGAM (0.89) | MGAMPTPN1CYP3A4NPC1HSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | claimed |
| EP-4072558-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-10-19 | — | — | EP | claimed |
| US-20240344028-A1 | Serum-free media for producing adipocytes for animal consumption | Mosa Meat B.V. (NL) | 2024-10-17 | — | — | US | disclosed |
| EP-4373918-A1 | SERUM-FREE MEDIA FOR PRODUCING ADIPOCYTES FOR ANIMAL CONSUMPTION | Mosa Meat B.V. (NL) | 2024-05-29 | — | — | EP | disclosed |
| WO-2023003471-A1 | METHOD FOR PRODUCING CULTURED FAT FOR ANIMAL CONSUMPTION. | Mosa Meat B.V. (NL) | 2023-01-26 | — | — | WO | disclosed |
| WO-2023003470-A1 | SERUM-FREE MEDIA FOR PRODUCING ADIPOCYTES FOR ANIMAL CONSUMPTION. | Mosa Meat B.V. (NL) | 2023-01-26 | — | — | WO | disclosed |
| US-20230012268-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD (IL) | 2023-01-12 | — | — | US | disclosed |
| EP-4072558-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATION WITH STEROIDS AND A MODULATOR | Buzzelet Development And Technologies Ltd (IL) | 2022-10-19 | — | — | EP | disclosed |